Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher M Overall

Showing results (121-130 of 233) with videos related to

Pageof 24
Sort By:
Molecular Systems Biology|January 14, 2017
Interactome disassembly during apoptosis occurs independent of caspase cleavageNichollas E Scott, Lindsay D Rogers, Anna Prudova, et al.
British Journal of Pharmacology|December 6, 2002
Identification, regulation and role of tissue inhibitor of metalloproteinases-4 (TIMP-4) in human plateletsAnna Radomski, Paul Jurasz, Esmond J Sanders, et al.
The Journal of Biological Chemistry|October 11, 2002
Utilization of a novel recombinant myoglobin fusion protein expression system to characterize the tissue inhibitor of metalloproteinase (TIMP)-4 and TIMP-2 C-terminal domain and tails by mutagenesis. The importance of acidic residues in binding the MMP-2 hemopexin C-domainHeidi S-T Kai, Georgina S Butler, Charlotte J Morrison, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 22, 2009
CXCR3 activation by lentivirus infection suppresses neuronal autophagy: neuroprotective effects of antiretroviral therapyYu Zhu, David Vergote, Carlos Pardo, et al.
Molecular and Cellular Biology|October 3, 2007
Identification of candidate angiogenic inhibitors processed by matrix metalloproteinase 2 (MMP-2) in cell-based proteomic screens: disruption of vascular endothelial growth factor (VEGF)/heparin affin regulatory peptide (pleiotrophin) and VEGF/Connective tissue growth factor angiogenic inhibitory complexes by MMP-2 proteolysisRichard A Dean, Georgina S Butler, Yamina Hamma-Kourbali, et al.
The Biochemical Journal|January 16, 2007
Cell surface chondroitin sulfate glycosaminoglycan in melanoma: role in the activation of pro-MMP-2 (pro-gelatinase A)Joji Iida, Krista L Wilhelmson, Janet Ng, et al.
Plos Pathogens|August 22, 2014
RC1339/APRc from Rickettsia conorii is a novel aspartic protease with properties of retropepsin-like enzymesRui Cruz, Pitter Huesgen, Sean P Riley, et al.
Diabetes|November 10, 2012
The peri-islet basement membrane, a barrier to infiltrating leukocytes in type 1 diabetes in mouse and humanÉva Korpos, Nadir Kadri, Reinhild Kappelhoff, et al.
Journal of Virology|July 2, 2024
Identification of the proteolytic signature in CVB3-infected cellsMarli Vlok, Nestor Solis, Jibin Sadasivan, et al.
Plos One|September 26, 2013
Proteomic amino-termini profiling reveals targeting information for protein import into complex plastidsPitter F Huesgen, Meriem Alami, Philipp F Lange, et al.
Pageof 24

Showing results (121-130 of 233) with videos related to

Sort By:
Pageof 24
Molecular Systems Biology|January 14, 2017
Interactome disassembly during apoptosis occurs independent of caspase cleavageNichollas E Scott, Lindsay D Rogers, Anna Prudova, et al.
British Journal of Pharmacology|December 6, 2002
Identification, regulation and role of tissue inhibitor of metalloproteinases-4 (TIMP-4) in human plateletsAnna Radomski, Paul Jurasz, Esmond J Sanders, et al.
The Journal of Biological Chemistry|October 11, 2002
Utilization of a novel recombinant myoglobin fusion protein expression system to characterize the tissue inhibitor of metalloproteinase (TIMP)-4 and TIMP-2 C-terminal domain and tails by mutagenesis. The importance of acidic residues in binding the MMP-2 hemopexin C-domainHeidi S-T Kai, Georgina S Butler, Charlotte J Morrison, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 22, 2009
CXCR3 activation by lentivirus infection suppresses neuronal autophagy: neuroprotective effects of antiretroviral therapyYu Zhu, David Vergote, Carlos Pardo, et al.
Molecular and Cellular Biology|October 3, 2007
Identification of candidate angiogenic inhibitors processed by matrix metalloproteinase 2 (MMP-2) in cell-based proteomic screens: disruption of vascular endothelial growth factor (VEGF)/heparin affin regulatory peptide (pleiotrophin) and VEGF/Connective tissue growth factor angiogenic inhibitory complexes by MMP-2 proteolysisRichard A Dean, Georgina S Butler, Yamina Hamma-Kourbali, et al.
The Biochemical Journal|January 16, 2007
Cell surface chondroitin sulfate glycosaminoglycan in melanoma: role in the activation of pro-MMP-2 (pro-gelatinase A)Joji Iida, Krista L Wilhelmson, Janet Ng, et al.
Plos Pathogens|August 22, 2014
RC1339/APRc from Rickettsia conorii is a novel aspartic protease with properties of retropepsin-like enzymesRui Cruz, Pitter Huesgen, Sean P Riley, et al.
Diabetes|November 10, 2012
The peri-islet basement membrane, a barrier to infiltrating leukocytes in type 1 diabetes in mouse and humanÉva Korpos, Nadir Kadri, Reinhild Kappelhoff, et al.
Journal of Virology|July 2, 2024
Identification of the proteolytic signature in CVB3-infected cellsMarli Vlok, Nestor Solis, Jibin Sadasivan, et al.
Plos One|September 26, 2013
Proteomic amino-termini profiling reveals targeting information for protein import into complex plastidsPitter F Huesgen, Meriem Alami, Philipp F Lange, et al.
Pageof 24